Hepatitis C and the skin

Dermatologic Clinics

Volumn 20, Issue 3, 2002, Pages 449-458

  Jackson, J Mark ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; AMANTADINE; HEPATITIS C ANTIBODY; METHOTREXATE; RIBAVIRIN;

ALOPECIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW SUPPRESSION; CRYOGLOBULINEMIA; DEPRESSION; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; FLU LIKE SYNDROME; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; LIVEDO RETICULARIS; LIVER TOXICITY; POLYARTERITIS NODOSA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; SKIN MANIFESTATION; URTICARIA; VIRUS TRANSMISSION; VITILIGO; PATHOLOGY; SKIN DISEASE;

HEPATITIS C; HUMAN; SKIN DISEASES; HUMANS;

EID: 0035990791     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00013-X     Document Type: Review

References (100)

1. Hepatitis C: A review and update
2. Chronic hepatitis C and skin diseases: A review
3. Hepatitis C
4. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations
5. Hepatitis C virus infection
6. Management of hepatitis C
7. Extrahepatic manifestations of chronic viral hepatitis
8. Epidemiology of hepatitis C
9. Preventing the spread of hepatitis B and C viruses: Where are germicides relevant
10. Transmission of hepatitis C virus by a cardiac surgeon
11. Hepatitis C virus infection in medical personnel after needlestick accident
12. Transmission of hepatitis C via blood splash into conjunctiva
13. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection
14. Commercial tattooing as a potentially important source of hepatitis C infection
15. The prevalence of hepatitis C virus in the United States, 1988-1994
16. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients
17. Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10 year follow-up
18. Erythema nodosum and hepatitis C
19. Hepatitis C virus infection in the mothers and infants cohort study
20. Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers
21. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin
22. High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease
23. Sexual and perinatal transmission of hepatitis C
24. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
25. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia
26. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
27. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: Variability and stability
28. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
29. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study
30. Clinical outcomes after transfusion-associated hepatitis C
31. Correlation between virus genotype and chronicity rate in acute hepatitis C
32. Persistence of viremia and the importance of long term follow-up after acute hepatitis C infection
33. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening
34. Epidemiological risk factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6664 patients
35. Chronic hepatitis C, cryoglobulinemia, and cutaneous necrotizing vasculitis
36. Essential mixed cryoglobulinemia: A comparative study of dermatologic manifestations in patients infected and noninfected with hepatitis C virus
37. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia
38. Symmetric polyarthritis with livedo reticularis: A newly recognized manifestation of hepatitis C virus infection
39. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
40. Hepatitis C and porphyria cutanea tarda
41. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection
42. Incidence of hepatitis C in lichen planus
43. Lichen planus and hepatitis C virus related chronic active hepatitis
44. Successful interferon treatment for lichen planus associated with chronic active hepatitis due to hepatitis C virus infection
45. Lichen planus and hepatitis C virus: Prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection
46. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease
47. Hepatitis C virus infection in patients with urticaria
48. Urticarial vasculitis caused by hepatitis C virus infection: Response to interferon alfa therapy
49. Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections
50. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa
51. Pruritus as a symptom of hepatitis C
52. Systemic vasculitis in patients with hepatitis C
53. Association of prurigo with hepatitis C virus infection
54. Hepatitis C virus infection in cutaneous polyarteritis nodosa: A retrospective study of 16 cases
55. Erythema multiforme and hepatitis C
56. Lichen planus, erythema nodosum, and erythema multiforme in a patient with chronic hepatitis C
57. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa
58. Unilateral nevoid telangiectasia: Occurrence in two patients with hepatitis C
59. Hepatitis C virus infection in patients with psoriasis
60. Psoriasis and hepatitis C virus
61. Possible association between Behçet's syndrome and chronic hepatitis C virus infection
62. Mooren's corneal ulcers and hepatitis C virus infection
63. Mooren ulcer in South India: Serology and clinical risk factors
64. Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma
65. Chronic hepatitis C virus infection associated with a generalized granuloma annulare
66. Necrolytic acral erythema: A cutaneous marker of hepatitis C
67. Hepatitis C virus infection mimicking systemic lupus erythematosus: Study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus
68. Thrombocytopenia associated with hepatitis C viral infection
69. Lymphoproliferative diseases and hepatitis C virus infection
70. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia
71. Primary cutaneous B-cell lymphoma: An association of chronic hepatitis C infection
72. Prevalence of hepatitis C virus infection in patients with lymphoproliferative, disorders in Southern Turkey
73. Systemic sclerosis: Another rheumatic disease associated with hepatitis C virus infection
74. Recommendations for prevention and control of hepatitis C virus (HCV) and HCV-related chronic disease
75. The interferons
76. National Institutes of Health
77. Canities and vitiligo complicating interferon therapy for hepatitis C
78. Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection
79. Alopecia areata induced by interferon alpha?
80. Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy
81. Acute hemolytic anemia during interferon-alpha therapy for chronic hepatitis C
82. Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data
83. Response to interferon alpha treatment and disappearance of cryoglobulinemia in patients infected by hepatitis C virus
84. Interferon alfa2a therapy in cryoglobulinemia associated with hepatitis C virus
85. Peginterferon alfa-2a inn patients with chronic hepatitis C
86. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon
87. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
88. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
89. Successful treatment of HCV-associated cryoglobulinemic glomerulonephritis with a combination of interferonalpha and ribavirin
90. Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: A randomized trial
91. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus
92. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders
93. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
94. GBV-C/HGV and HCV infection in mixed cryoglobulinemia
95. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C of B virus infection
96. Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases
97. Effects of corticosteroids on HCV infection
98. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
99. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
100. Detection of hepatitis C virus RNA in amniotic fluid: A prospective study